Recombinant Albumin Market

Recombinant albumin is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.

Recombinant Albumin Market contains market size and forecasts of Recombinant Albumin in global, including the following market information:

• Global Recombinant Albumin Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Recombinant Albumin Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Recombinant Albumin companies in 2021 (%)

The global Recombinant Albumin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

OsrHSA Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Albumin include Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen and HiMedia, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

surveyed the Recombinant Albumin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Albumin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant Albumin Market Segment Percentages, by Type, 2021 (%)

• OsrHSA
• ScrHSA

Global Recombinant Albumin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant Albumin Market Segment Percentages, by Application, 2021 (%)

• Cell Culture Media
• Medical Supplements
• Other

Global Recombinant Albumin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant Albumin Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Recombinant Albumin revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Recombinant Albumin revenues share in global market, 2021 (%)
• Key companies Recombinant Albumin sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Recombinant Albumin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Albumedix
• Merck
• Ventria (InVitria)
• NCPC
• Oryzogen
• HiMedia